These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Sporadic distal myopathy]. Il'ina NA; Aver'ianov IuN; Nechkina NP; Potomskaia LZ; Sokolina NA Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(11):1620-3. PubMed ID: 6675357 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial disease mimicking Charcot-Marie Tooth disease. Needham M; Duley J; Hammond S; Herkes GK; Hirano M; Sue CM J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):99-100. PubMed ID: 17172573 [No Abstract] [Full Text] [Related]
6. Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report. Kulkarni SD; Sayed R; Garg M; Patil VA Neuromuscul Disord; 2015 Nov; 25(11):916-9. PubMed ID: 26432165 [TBL] [Abstract][Full Text] [Related]
7. Central sleep apnoeas in patients with Charcot-Marie-Tooth disease. Teramoto S; Ishii T; Matsuse T Lancet; 2001 Jul; 358(9275):70-1. PubMed ID: 11458935 [No Abstract] [Full Text] [Related]
8. Axonal Charcot-Marie-Tooth disease: the fog is slowly lifting! Reilly MM Neurology; 2005 Jul; 65(2):186-7. PubMed ID: 16043782 [No Abstract] [Full Text] [Related]
9. A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia. Luigetti M; Modoni A; Renna R; Silvestri G; Ricci E; Montano N; Tasca G; Papacci M; Monforte M; Conte A; Pomponi MG; Sabatelli M Clin Neurol Neurosurg; 2010 Nov; 112(9):794-7. PubMed ID: 20537790 [TBL] [Abstract][Full Text] [Related]
10. Serum enzymes in peroneal muscular atrophy (Charcot-Marie-Tooth disease). Switala KJ; Robinson N; Sances A; Larson S; Evans SM; Pintar K Wis Med J; 1977 Jan; 76(1):S4-6. PubMed ID: 835307 [No Abstract] [Full Text] [Related]
11. Charcot-Marie-Tooth neuropathy type 1A combined with Duchenne muscular dystrophy. Vondracek P; Hermanova M; Sedlackova J; Fajkusova L; Stary D; Michenkova A; Gaillyova R; Seeman P; Mazanec R Eur J Neurol; 2007 Oct; 14(10):1182-5. PubMed ID: 17880576 [TBL] [Abstract][Full Text] [Related]
12. The shifting landscape of genetic testing for Charcot-Marie-Tooth disease. England JD Muscle Nerve; 2014 Apr; 49(4):467-8. PubMed ID: 24006101 [No Abstract] [Full Text] [Related]
13. Motor neuron disease of very long disease duration or Charcot-Marie-Tooth disease? A novel phenotype related to the SOD1 p.E22G variant. Querin G; Corcia P; Lenglet T; Stojkovic T; Leguern E; Cazeneuve C; Pradat PF Rev Neurol (Paris); 2017 Dec; 173(10):671-673. PubMed ID: 28579206 [No Abstract] [Full Text] [Related]
16. [Incidence and clinical polymorphism of Charcot-Marie neural amyotrophy in the Amur region]. Khomenko EI Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(11):22-6. PubMed ID: 7180298 [No Abstract] [Full Text] [Related]
17. [Contribution of molecular genetics to the diagnosis of Charcot-Marie-Tooth disease]. Goldber-Stern H; Navon R; Gadoth N Harefuah; 1995 Jun; 128(11):700-3. PubMed ID: 7557669 [No Abstract] [Full Text] [Related]
18. A commentary on Molecular diagnosis and clinical onset of Charcot-Marie-Tooth disease in Japan. Nakagawa M J Hum Genet; 2011 May; 56(5):341-2. PubMed ID: 21451531 [No Abstract] [Full Text] [Related]
20. Data on three of the original patients of Roussy and Levy (1926). Salisachs P; Findley LJ; Codina M; La Torre P; Martinez-Lage JM Muscle Nerve; 1982 Oct; 5(8):663-4. PubMed ID: 7155179 [No Abstract] [Full Text] [Related] [Next] [New Search]